Clinical Trial Update: Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial evaluating the diagnostic PET tracer [68Ga]Ga-XT771 for glioblastoma and clear cell renal cell carcinoma, currently recruiting at the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Glioblastoma

Drugs mentioned

• [68Ga]Ga-XT771 (XT771)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Clear Cell Renal Cell Carcinoma and Glioblastoma | EARLY_Phase 1 | Status: RECRUITING